NexImmune Inc. Gains 144.94%
Fri, Dec 01, 2023 at 07:42 PM
NexImmune Inc. (NEXI:NASDAQ) soared at $6.05, a gain of 144.9%. On Fri, Dec 01, 2023, NEXI:NASDAQ hit a New 2-Week High of $6.05. The stock got featured on our News Catalysts scanner on Fri, Dec 01, 2023 at 02:08 PM in the 'HALT' category. From Mon, Nov 20, 2023, the stock recorded 37.50% Up Days and 33.33% Green Days
The stock spiked on Fri, Dec 01, 2023 at $8.46 with a volume of 15M+.
About NexImmune Inc. (NEXI:NASDAQ)
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology.
Top 10 Gainers:
- Kubient Inc. (KBNT:NASDAQ), 175%
- NexImmune Inc. (NEXI:NASDAQ), 144.94%
- Green Giant Inc Com (New) (GGE:NASDAQ), 66.43%
- View Inc. (VIEW:NASDAQ), 63.26%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 59.76%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 52.07%
- Pineapple Financial Inc. (PAPL:NYSEMKT), 50.68%
- Newegg Commerce Inc. (NEGG:NASDAQ), 42.86%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 39.52%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 39.05%